NHS logo
NHS logo
The CVD Prevention Fellowship was a quality improvement programme for primary care clinicians in south London.
Covid-19 posed many challenges to the delivery of routine primary care, including the completion of annual diabetes reviews. During this time, the You and Type 2 Risk Stratified Pathway was developed
You and Type 2 at Home was a proof of concept pilot for a fully remote type 2 diabetes annual review pathway. It was developed during the peak of the Covid-19 pandemic, when primary care clinicians we
The HIN’s ESCAPE-pain team received requests from sites that were eager to pilot ESCAPE-pain classes using a digital platform. The team adapted to meet this need and supported sites to trial virtual
The Health Innovation Network (HIN), in partnership with the End of Life Clinical network for London, secured funding from the NHS England (NHSE) personalisation team to work with Marie Curie nurses t
The HIN partnered with training provider Hayat Consultancy to run a pilot online My Wellbeing training course for care home staff in south London to improve mental wellbeing. This was intended to supp
The Rapid Uptake Products (RUP) programme has been designed to support stronger adoption and spread of proven innovations. It identifies and supports products with NICE approval that support the NHS L
The MedTech Funding Mandate (MTFM) policy aims to support getting effective and innovative medical devices, diagnostics and digital products to patients faster. This mandate will pilot with four forme
Coronary heart disease (CHD) is the world’s number one killer, accounting for 15% of UK deaths in 2019¹. HeartFlow FFRCT analysis provides clinicians with a more efficient pathway for diagnosing CH
Pre-eclampsia (PE) affects approximately three per cent of all pregnancies and is a serious cause of maternal and foetal morbidity. There is no definitive test to help diagnose PE and the only “cure
SecurAcath is a small orange triangular device to afix a PICC or Vascular catheter to the patient by the skin through two subcutaneous hooks. It is on the Innovation and Technology Payment (ITP) progr
GammaCore is a simple-to-use, handheld medical device that enables patients to self-administer discrete doses of non-invasive vagus nerve stimulation (nVNS) therapy to the neck. Project overviewCluste
The 2020/21 ITP programme supports NHS England’s commitment to accelerate the adoption and spread of proven and affordable innovations. The programme removes some of the financial and procurement ba
FeNO (Fractional exhaled Nitric Oxide) [NICE DG12] testing alongside other recommended NICE diagnostic tests, will help enable more accurate diagnosis of asthma. Over 120,000 patients a year, 30% of t
What are Asthma Biologics? A group of medicines prescribed in Severe Asthma Centres (SACs) to treat a group of people with asthma (eosinophilic asthma or severe persistent allergic asthma) who continu
PINCER is the Pharmacist-led Information technology iNtervention for the reduction of Clinically important ERrors in medicines management. Project overviewPINCER searches GP clinical systems using com
In 2019, 45.6% and 20.7% of London ‘years lived with disability’ (YLD) following CHD or stroke respectively were attributed to high LDL cholesterol¹. The Rapid Uptake Product for lipid management
The HIN has been commissioned to support a drive to equip members and partners to offer the Covid Oximetry @home model.
Project overview Health Innovation Network and My Home Life are delighted to announce the third South London Care Home Pioneer Programme – a FREE leadership support and professional development
Guy’s and St Thomas’ YES programme gives 14-19 year-olds in south London the support they need to live with Type 1 diabetes. Participants meet other young people with Type 1 diabetes, building con
In 2020, the HIN worked with the South East London Integrated Care System to explore how modern telephony systems can impact primary care service delivery. This culminated in the creation of a telepho
We are supporting three rheumatology departments across south east London (SEL) to trial a new service that supports patients with rheumatoid arthritis (RA) to remotely monitor their condition. The se
The HIN engaged with OPUS and commissioned them on a pro bono basis to adapt their existing comprehensive guidance to ensure care home staff were aware of how to safely administer medicines without us
With outpatient appointments reduced due to the pandemic, the South East London Diabetes Foot Network which covers seven London boroughs and a population of two million, had to continue high-quality,